In vitro methionine5-enkephalin degradation kinetics by human brain preparations

Neurochemical Research

Volumn 33, Issue 1, 2008, Pages 81-86

  Mosnaim, Aron David ^a,b   Nguyen, Tao D ^c   Tse, Robert ^a   Puente, Javier ^d   Couceyro, Pastor ^a   Wolf, Marion E ^e  

^a Chicago Medical School RFUMS   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c VIETNAM MILITARY MEDICAL UNIVERSITY   (Viet Nam)

^d UNIVERSITY OF CHILE   (Chile)

^e International Neuropsychiatry Consultants   (United States)

Author keywords

Aminopeptidase; Aminopeptidase inhibitors; Human brain areas; Methionine enkephalin degradation kinetics

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METENKEPHALIN; THIORPHAN; TYROSINE;

ADULT; AGED; ARTICLE; CASE REPORT; CONTROLLED STUDY; DRUG HALF LIFE; DRUG METABOLISM; HUMAN; HUMAN TISSUE; IN VITRO STUDY; KINETICS; MALE; PH; PRIORITY JOURNAL; TEMPERATURE; BRAIN; HALF LIFE TIME; METABOLISM; MIDDLE AGED;

AGED; BRAIN; ENKEPHALIN, METHIONINE; HALF-LIFE; HUMANS; KINETICS; MALE; MIDDLE AGED;

EID: 36949034306     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9418-6     Document Type: Article

References (26)

1. Cox BM (1988) Peripheral actions mediated by opioid receptor. In: Pasternak GW (ed) The opioid receptors. Humana Press, Clifton, NJ, pp 357-424
2. Kandel ER, Schwartz JH, Jessell TM (2000) Principles of Neural Science, 4th edn. (revised) New York, McGraw-Hill
3. Wolf ME, Mosnaim AD, Ignacio R, Puente J (1991) Plasma methionine-enkephalin in post-traumatic stress disorder. Biol Psychiatry 29:305-307
4. Babst R, Bongiorno L, Marini M, Roda G, Spagnoli G, Urbani A (1999) Trauma decreases leucine enkephalin hydrolysis in human plasma. J Pharmacol Exp Ther 288:766-773
5. Waldenlind E, Bussone G (2006) Biochemistry, circannual and circadian rtythms, endocrinology, and immunology of cluster headaches. In: Olesen J et al (ed) The headaches, 4th edn. Lippincott Williams & Wilkins, PA
6. Puente J, Mosnaim AD, Wolf M (2006) Stress, Opioid peptides and the immune response. In: Plotnikoff N et al (ed) Stress, cytokines and the immune response. CRC Press, Taylor & Francis Group, NY, pp 125-142
7. Spano MS, Ellgren M, Wang X, Hurd YL (2007) Prenatal cannabis exposure increases heroin seeking with allostatic changes in limbic enkephalin systems in adulthood. Biol Psychiatry 61:554-563
8. Hambrook JM, Morgan BA, Rance MJ, Smith CF (1976) Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates. Nature 262:782-783
9. Jakubovic A (1988) Degradation of met-enkephalin by extracts of various regions of the human brain: effects of antipsychotics and narcotics in vitro. Peptides 3:21-26
10. Wolf ME, Szanto P, Marks S, Tung NP, Mosnaim AD (1993) Methionine-enkephalin metabolism by human brain preparations. Soc Biol Psychiatry, CA (Abstract)
11. McDermott JR, Mantle D. Lauffart B, Kidd AM (1985) Purification and characterization of a neuropeptide-degrading aminopeptidase from human brain. J Neurochem 45:752-759
12. Hui K-S, Lajtha A (1983) Neuropeptidases. In: Lajtha A (ed) Enzymes in the nervous system handbook of neurochemistry, 2nd edn., vol 4. Plenum, New York, NY, pp 1-19
13. Taylor A, Jason Warner (2002) Aminopeptidases. In: Smith J, Simons C (eds) Proteinase and peptidase inhibition. Taylor & Francis Group, NY
14. Gerhartz B, Niestroj AJ, Demuth H-U (2002) Enzyme classes and mechanisms. In: Smith J, Simons CP (eds) Proteinase and peptidase inhibition. Taylor & Francis Group, NY
15. Mosnaim AD, Puente J, Ranade V, Hoang C, Wolf ME (2004) Inhibition of human plasma leucine-enkephalin aminopeptidase hydrolysis by various endogenous peptides and a select number of clinically used drugs. Am J Ther 11:459-465
16. Ranade VR, Wolf ME, Puente J, Valenzuela MA, Mosnaim AD (2006) Phenothiazine molecule provides the basic chemical structure for various classes of pharmacotherapeutic agents. Am J Ther 13:261-273
17. Mosnaim AD, Wolf ME, Nguyen TD, Puente J, Freitag F, Diamond S (2000) Degradation kinetics of leucine-enkephalin by plasma samples from healthy controls and various patient populations: in vitro drug effects. Am J Ther 7:185-194
18. Mosnaim AD, Puente J, Saavedra R, Diamond S, Wolf ME (2003) In vitro human plasma leucine-enkephalin degradation is inhibited by a select number of drugs with the phenothiazine molecule in their chemical structure. Pharmacology 67:6-13
19. Altstein M, Mittman S, Vogel Z (1981) The effect of barbiturates on the degradation of enkephalin by brain enzymes. Life Sci 28:185-191
20. Traficante LJ, Turnbull B (1982) Neuropeptide degrading enzyme(s) in plasma and brain: effect of in vivo neuroleptic administration. Pharmac Res Commun 14:341-348
21. Agam G, Everall IP, Belmaker RH (2002) The postmortem brain in psychiatric research. Kluwer Academic Publishers, Boston, MA
22. Wolf, ME, Tung NP, Lee H, Shen J, Mosnaim AD (1993) Leucine-enkephalin (LEU) metabolism by human brain preparations. FASEB (Abstract)
23. Venturelli F, Roscetti G, Possenti R, Vita F, Roda GL (1985) Peripheral enkephalin hydrolysis in different animal species: a comparative study. Neurochem Res 10:333-342
24. Mosnaim AD, Puente J, Wolf ME, Callaghan OH, Bush R, Diamond S (1988) Studies of the in vitro human plasma degradation of methionine-enkephalin. Gen Pharmacol 19:729-733
25. Malfroy B, Swerts JP, Guyon A, Roques BP, Schwartz JC (1978) High-affinity enkephalin-degrading peptidase in brain is increased after morphine. Nature 276:523-526
26. Clement-Jones V, Loury PJ, Rees LH, Besser JM (1980) Met-enkephalin circulates in human plasma. Nature 283:295-297